炎症性皮肤病临床实践中的提供者整体评估质量指标
国际皮肤病结局测量组织与美国皮肤病学会通过改良德尔菲法,就炎症性皮肤病的提供者评估整体疾病严重程度指标达成共识。文献回顾后36名成员参与,银屑病、特应性皮炎和痤疮获得绝大多数共识,并同意使用5点序数量表,描述符通过参考电子平台提供。
要点
- 银屑病、特应性皮炎和痤疮获得绝大多数共识,可作为整体疾病严重程度指标测量的炎症性皮肤病。
- 共识采用5点序数量表,描述符通过参考电子平台提供。
- 专家开发纳入该指标的质量指标并将其纳入数据收集平台,对皮肤科医生证明诊疗价值至关重要。
核心结论
- 国际皮肤病结局测量组织与美国皮肤病学会通过改良德尔菲法就炎症性皮肤病的提供者评估整体疾病严重程度指标达成共识。
研究设计与样本
- 国际皮肤病结局测量组织与美国皮肤病学会合作,通过改良德尔菲法寻求共识,并进行文献回顾以提供信息。
- 文献回顾后,36名国际皮肤病结局测量组织与美国皮肤病学会成员参与改良德尔菲法过程。
主要发现
- 银屑病、特应性皮炎和痤疮获得绝大多数共识,可作为整体疾病严重程度指标测量的炎症性皮肤病。
- 共识还就使用5点序数量表达成一致,描述符通过参考电子平台提供。
关键数值与推荐
- 共识采用5点序数量表,描述符通过参考电子平台提供。
临床怎么用
- 专家开发纳入该指标的质量指标并将其纳入数据收集平台,对使皮肤科医生能够证明为严重炎症性皮肤病患者提供的诊疗价值至关重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In our evolving health care system, dermatologists are increasingly being asked to prove the value of care they provide to patients with severe skin diseases. Current quality measures for inflammatory dermatoses have limited validity and feasibility. Through collaboration and a modified Delphi process, International Dermatology Outcome Measures and the American Academy of Dermatology sought to reach consensus on a valid and feasible provider-assessed global disease severity metric to be incorporated into a quality measure for inflammatory dermatoses. To inform the modified Delphi process, a review of the literature was performed, and data were collected on current provider-assessed global disease severity metrics. After literature review, 36 members of International Dermatology Outcome Measures and the American Academy of Dermatology participated in the modified Delphi process to reach consensus on features of the metric. Psoriasis, atopic dermatitis, and acne achieved overwhelming consensus for inflammatory dermatoses that could be measured in a global disease severity metric. Consensus was also reached on the use of a 5-point ordinal scale with descriptors provided through referenced electronic platforms. Expert development of quality measures incorporating this metric and its inclusion in data collection platforms are critical to enabling dermatologists to prove the value of care provided to patients with severe inflammatory dermatoses.
引用
- Gottlieb A, Salame N, Armstrong AW, et al. A provider global assessment quality measure for clinical practice for inflammatory skin disorders. J Am Acad Dermatol. 2018. PMID: 30244058. doi:10.1016/j.jaad.2018.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。